Sagimet Biosciences Inc.SGMTNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-45.57M
↓ 75% below average
Average (5y)
$-26.10M
Historical baseline
Range
High:$-11.40M
Low:$-45.57M
CAGR
+26.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-45.57M | -48.2% |
| 2023 | $-30.74M | +1.0% |
| 2022 | $-31.05M | -30.9% |
| 2021 | $-23.72M | -108.1% |
| 2020 | $-11.40M | +19.2% |
| 2019 | $-14.11M | - |